SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-043393
Filing Date
2011-05-03
Accepted
2011-05-03 08:44:57
Documents
13
Period of Report
2011-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d81838e8vk.htm 8-K 18500
2 EX-4.1 d81838exv4w1.htm EX-4.1 90511
3 EX-5.1 d81838exv5w1.htm EX-5.1 9047
4 EX-10.1 d81838exv10w1.htm EX-10.1 165359
5 EX-99.1 d81838exv99w1.htm EX-99.1 10407
6 GRAPHIC d81838d8183801.gif GRAPHIC 4256
7 GRAPHIC d81838d8183802.gif GRAPHIC 4338
8 GRAPHIC d81838d8183803.gif GRAPHIC 1722
9 GRAPHIC d81838d8183804.gif GRAPHIC 4374
10 GRAPHIC d81838d8183805.gif GRAPHIC 4608
11 GRAPHIC d81838d8183806.gif GRAPHIC 1925
12 GRAPHIC d81838d8183807.gif GRAPHIC 4308
13 GRAPHIC d81838d8183808.gif GRAPHIC 8750
  Complete submission text file 0000950123-11-043393.txt   343364
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51820 | Film No.: 11802979
SIC: 2834 Pharmaceutical Preparations